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Abstract
Objectives Global left ventricular (LV) function is routinely used to assess cardiac function; however, myocardial strain is able to
identify more subtle dysfunction. We aimed to determine the recovery and prognostic value of featuring tracking (FT) cardio-
vascular magnetic resonance (CMR) strain in ST-segment elevation myocardial infarction (STEMI) patients with a concurrent
chronic total occlusion (CTO).
Methods In the randomized EXPLORE trial, there was no significant difference in global LV function after percutaneous
coronary intervention (PCI) of the CTO, compared with no-CTO PCI, post-STEMI. In the current study, we included 200 of
the 302 EXPLORE patients with a baseline CMR, of which 180 also had 4-month follow-up (serial) CMR. Global longitudinal
strain (GLS) was calculated from 3 long-axis views. Global circumferential strain (GCS) and segmental strain were calculated
from 3 short-axis views (basal, mid, and apical).
Results Global strain significantly improved at 4 months (GLS Δ − 1.8 ± 4.3%, p< 0.001; GCS Δ − 1.7 ± 4.7%, p < 0.001); however,
there was no treatment effect of CTO-PCI on strain recovery. GLSwas a significant predictor for 4 months of LVejection fraction (p=
0.006), incremental to other CMR parameters including infarct size. For mortality, infarct size remained the strongest predictor. On
regional level, segmental strain independently predicted recovery in the dysfunctional segments (p < 0.001).
Conclusions Global and segmental myocardial strains significantly improved over time, with no effect of CTO-PCI. Global strain
was associated with outcome and segmental strain was an independent predictor for regional LV recovery in the dysfunctional
CTO territory. Further research is needed to determine the additional prognostic value of strain beyond routine CMR parameters.
Key Points
• In STEMI patients with a concurrent CTO, strain significantly improves over time, regardless of CTO-PCI.
• Global strain is an independent predictor for functional recovery, incremental to infarct size, LVEF, and clinical parameters.
• Segmental strain was able to predict the recovery of wall thickening, incremental to transmural extent of infarction.
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CMR Cardiovascular magnetic resonance
CTO Chronic total occlusion
EXPLORE Evaluating Xience and left ventricular function
in PCI on occlusiOns afteR STEMI
FT Feature tracking
GCS Global circumferential strain
GLS Global longitudinal strain
IRA Infarct-related artery
LGE Late gadolinium-enhanced
LVEDV Left ventricular end-diastolic volume
LVEF Left ventricular ejection fraction
MVO Microvascular obstruction
PCI Percutaneous coronary intervention
SSFP Steady-state free-precision
STEMI ST-segment elevation myocardial infarction
SWT Segmental wall thickening
TEI Transmural extent of infarction
Introduction
Cardiovascular magnetic resonance (CMR) is frequently used
for non-invasive assessment of global left ventricular (LV)
function and infarct size, which can be used as surrogate end-
points to predict clinical outcome of ST-segment elevation
myocardial infarction (STEMI) patients [1]. However, more
subtle but important contractile changes might not be detect-
ed, as these do not always lead to a decline in global LV
function. Currently, new techniques, such as myocardial strain
parameters, are therefore gaining more interest as they are able
to identify subtle myocardial deformation, are less subjective,
and are less experience-dependent [2]. The reference method
for the quantification of cardiac LV deformation is myocardial
tissue tagging; however, this technique requires additional im-
age acquisition and post-processing analysis and is therefore
more time-consuming [3]. CMR-based feature tracking (FT)
is novel and highly correlated with myocardial tissue tagging,
but it is more clinically feasible as it uses the steady-state free-
precision cine images acquired with standard CMR protocols
[2, 4]. FT-CMR provides a fast and accurate assessment of
myocardial strain by following the border tracking over time
and defining the relative change in length of the myocardial
segment [5]. FT-CMR is reproducible and comparable values
are provided with different software methods [6, 7]. Global
longitudinal strain (GLS) and global circumferential strain
(GCS) are suggested to be more sensitive in detecting myo-
cardial contractility changes before there is a change in global
LV parameters and also to be less variable when compared
with LVejection fraction (LVEF) and wall motion analysis [8].
In STEMI patients with a concurrent chronic total occlu-
sion (CTO), neither the recovery and prediction of outcome
using global and segmental strains have thus far been
examined nor the effect of additional percutaneous coronary
intervention (PCI) of the CTO on the recovery of strain.
Currently, the treatment of the (accidently) found concurrent
CTO in STEMI patients during primary PCI remains contro-
versial. Observational data have suggested beneficial effects
of CTO-PCI [9]. However, the first randomized Evaluating
Xience and left ventricular function in PCI on occlusiOns
afteR STEMI (EXPLORE) trial, which included STEMI pa-
tients, after successful primary PCI, with a CTO and random-
ized patients to either CTO-PCI or no-CTO PCI, showed no
beneficial effect on global LV function (LVEF and LVEDV)
[10]. We used the patients included in the EXPLORE trial to
(1) investigate the recovery in global and segmental strain
parameters from baseline to follow-up, (2) study the effect
of CTO-PCI on this recovery, and (3) determine the incremen-
tal prognostic value of global and segmental strains in
predicting functional and clinical outcomes.
Methods
In the current sub-study from the EXPLORE trial, we in-
cluded all patients who underwent a baseline CMR (200 of
the 302 patients), of which 180 patients also had a 4-month
CMR (serial CMR). This cohort of patients with serial
CMR has been described before [11]. In these 200 patients,
offline strain analysis was performed; the other patients
(n = 102) were excluded because they lacked a baseline
CMR (a baseline CMR was not mandatory in the study
protocol). Details regarding the design and results of the
EXPLORE trial were previously reported [10, 12]. In
short, the randomized multi-center clinical EXPLORE trial
included 302 STEMI patients with a concurrent CTO and
randomized them in a 1:1 ratio to CTO-PCI within 7 days
after primary PCI (n = 148) or to a conservative strategy
(no-CTO PCI) for at least 4 months (n = 154). Important
inclusion criteria were the following: a concurrent CTO in
a non-infarct-related artery found during successful prima-
ry PCI for STEMI and the CTO had to be located in a
coronary vessel with a reference diameter of at least
2.5 mm. Among the exclusion criteria were the following:
> 48 hemodynamic instability and factors precluding reli-
able CMR imaging (atrial fibrillation, severe renal insuffi-
ciency, and pacemakers or implantable cardioverter-
defibrillators). Full inclusion and exclusion criteria are
summarized in the Supplemental File. CTO definition
was a 100% luminal narrowing without antegrade flow.
An independent angiography corelab assessed all coronary
angiographies. There were no significant differences in the
primary outcomes of LVEF and LV end-diastolic volume
(LVEDV) at 4 months of follow-up in patients randomized
to CTO-PCI compared with no-CTO PCI, nor on LV sys-
tolic volume, LV mass, and infarct size.
Eur Radiol
CMR protocol
All CMRs were performed on a 1.5-Tesla scanner using a
dedicated phased array cardiac receiver coil. ECG-gated
steady-state free-precession cine images for LV function im-
aging were obtained, during repeated breath holds, in long-
axis orientation (2-, 3-, and 4-chamber views) and in short-
axis orientation covering the left ventricle from base to apex.
Late gadolinium-enhanced (LGE) images were acquired using
an inversion recovery gradient-echo pulse sequence with slice
locations identical to the cine images to identify the size and
extent of infarction. Images were acquired at least 10 min after
administration of a gadolinium-based contrast agent in a dos-
age of 0.2 mmol/kg of body weight. Transmurality of scar
tissue of the myocardium was assessed in patients who
underwent baseline CMR of sufficient quality. To assess via-
bility, transmural extent of infarction (TEI) was used, TEI of
0–50% per segment was considered viable [13].
Wall thickening
The analysis of segmental wall thickening has been described
before [11]. An independent core laboratory, blinded for ran-
domization outcome, analyzed all CMR images (ClinFact
Corelab using QMass MR analytical software version 7.6,
Medis BV). A 16-segment model, excluding the apex, was
used to analyze wall thickening. Endo- and epicardial borders
on the end-diastolic and end-systolic images were manually
outlined on all short-axis cine slices. Segmental wall thicken-
ing was defined as a percentage increase of LV wall thickness
during systole compared with diastole. Myocardial segments
were considered dysfunctional if wall thickening was less than
45% [14]. Individual segments for each patient were assigned
to one of the major coronary arteries using the American Heart
Association standardized myocardial segmentation and no-
menclature statement [15]. Myocardial segments were
assigned to the CTO, infarct, or remote territory using this
standard model (in relation to the coronary anatomy scored
by the angiographic corelab).
Strain analysis
Strain measurements were performed offline using the FT-
CMR software method of Medis QStrain Software (Medis
Medical Imaging Systems, version 2.0.12.2.) (example of
the analysis is in the Supplementary File). All three
longitudinal-axis views (2-, 3-, and 4-chamber) were used to
determine peak GLS. Endocardial contours were manually
drawn during end-diastole and end-systole with subsequent
automatic tracking during the cardiac cycle. As an example,
a cine CMRmovie file of the endocardial tracking is available
as additional files 1 and 2. For the assessment of GCS and
segmental circumferential strain, the corelab contours for the
short-axis images were used. Peak GCSwas calculated from 3
short-axis views (basal, mid, and apical). For peak segmental
strain, short-axis images were used to define the segments
according to the 16-segment model after manual insertion of
a reference point (delineated at the anterior insertion of the
right ventricle). All studies were loaded into the software
and analyzed in a random order by one investigator blinded
for randomization outcome under supervision of a CMR car-
diologist with > 15-year experience (JE, supervisor: AH). The
reproducibility of GLS measurements was assessed in 30
CMR scans (15 patients with baseline and follow-up CMR).
The intraclass correlation coefficient for interobserver agree-
ment was 0.97 (95% CI 0.89 to 0.99; p < 0.001).
Clinical outcomes
At 4 months and 1, 2, 3, 4, and 5 years, clinical follow-up was
collected to assess survival status. Survival data were censored
at 5 years or known date of last contact [16].
Statistical analysis
Data are presented as mean ± standard deviation for continu-
ous variables. Discrete variables are presented as frequencies
and percentages. Baseline characteristics were compared
using the independent-samples t test, or Fisher’s exact proba-
bility test in case of binary endpoints. Analyses were per-
formed on intention-to-treat analysis. Changes in GLS and
GCS within each group were tested with paired Student’s
t test. Pearson’s correlation coefficient analysis was used to
assess the relationship between the global strain and LV func-
tion parameters. Multivariable linear regression was used for
testing the contribution of baseline, angiographic, and CMR
characteristics in relation to LVEF at follow-up. Stepwise for-
ward selection of variables was used; all variables with a
p value < 0.05 were included and variables with a p value >
0.10 were removed from the model. Cumulative event rates of
long-term mortality were estimated using Kaplan-Meier
curves, and the Log rank statistic was used for comparing
the survival curves. Hazard ratios for long-termmortality were
calculated, after verification of the proportional hazard as-
sumption, using Cox proportional hazard regression analyses.
We evaluated the recovery of segmental circumferential strain
in dysfunctional segments at baseline. Because within 1 pa-
tient the regional strain in the different segments is strongly
related and not an independent outcome, multilevel analysis
was used (linear regression) [17]. The following fixed effects
were included: randomization outcome and baseline segmen-
tal strain. Multilevel analysis was also used to look for predic-
tors of regional wall thickening recovery, and the following
fixed effects were included: baseline SWT, baseline
transmural extent of infarction, presence of microvascular ob-
struction, randomization outcome, and baseline segmental
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strain. All tests were two-sided, and a p value < 0.05 was
considered to indicate statistical significance. Statistical anal-
ysis was performed with the Statistical Package for Social
Sciences software (SPSS version 23.0 for Windows).
Results
Baseline characteristics
The baseline characteristics of the 200 patients included in this
study are shown in Supplement Table 1. Patients had a mean
age of 60 ± 10 years and 88% was male. Mean baseline LVEF
was 41 ± 12%, LVEDV 103 ± 25 ml/m2, and infarct size 12 ±
11 g. In the patients randomized to CTO-PCI, the PCI was
performed on day 5 ± 2 after primary PCI. Baseline CMRwas
performed 4 ± 2 days after primary PCI. Baseline GLS was
available in 184 patients and GCS in 176 patients. Serial GLS
measurements were available in 166 and serial GCS in 160
patients (Fig. 1). GLS and GCS by FT-CMRwere significant-
ly correlated with LVEF, LVEDV, and infarct size (p < 0.0001
for all). Changes in strain parameters were also related to
change in LVEF; however, change in LVEDVand infarct size
showed poor correlation with change in global strain
(Supplement Table 2).
Global myocardial strain at follow-up
GLS and GCS significantly improved from baseline to
4 months of follow-up (ΔGLS − 1.8 ± 4.3%, p < 0.001;
ΔGCS − 1.7 ± 4.7%, p < 0.001) (Fig. 2). However, there was
no treatment effect of CTO-PCI on the recovery of global
strain parameters (ΔGLS − 2.4 ± 4.2% versus − 1.4 ± 4.3%,
p = 0.14; ΔGCS − 1.4 ± 4.5% versus − 1.9 ± 4.9%, p = 0.55)
(Table 1).
Prognostic value of global strain
Both GLS and GCSwere univariate predictors for LVEF at
4-month follow-up. In multivariate analysis, GLS remained a
significant predictor for functional outcome (4-month LVEF)
(ß − 0.40, 95% CI − 0.68 to − 0.12, p = 0.006), together with
baseline LVEF, LVEDV, and presence of microvascular ob-
struction (MVO) (Table 2). By the Kaplan-Meier analysis, the
patients in the lowest quartile GCS (GCS > − 14%) had a sig-
nificantly worse survival compared with patients with GCS
< − 14% (Fig. 3). During a median follow-up of 4.0 (2.2–5.0)
years, 13 patients died (6.5%). Univariate predictors for long-
term mortality were LVEF, LVEDV, and GCS. In stepwise
forward multivariate analysis, GCS remained the strongest
predictor for mortality (HR 1.17, 95% CI 1.04–1.31, p =
0.009) (Supplement Table 3). In 74% of the patients, infarct
data was available; when including infarct size and MVO in
the model, infarct size was the only significant CMR param-
eter predicting mortality (HR 1.07, 95% CI 1.03–1.11,
p < 0.001).
Segmental circumferential strain at follow-up
There were 2560 segments available for serial segmental cir-
cumferential strain analysis (from n = 160 patients).
Segmental strain was significantly recovered from baseline
to 4-month follow-up in the dysfunctional segments (wall
thickening < 45% at baseline; Δ segmental strain − 2.4 (8.9),
p < 0.001; Table 3). However, no significant difference was
found between CTO-PCI and no-CTO PCI. Table 3 shows the
recovery of segmental strain in the dysfunctional segments in
Fig. 1 Flowchart of the EXPLORE trial and available cardiovascular magnetic resonance data. CTO = chronic total occlusion; PCI = percutaneous
coronary intervention; CMR = cardiac magnetic resonance; GLS = global longitudinal strain; GCS = global circumferential strain
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the CTO. In the CTO territory, no significant difference was
found on segmental strain between CTO-PCI and no-CTO
PCI (Δ segmental strain − 2.5 ± 9.5% versus − 2.5% ± 8.5%,
p = 0.50).
Prediction of wall thickening recovery with segmental
strain
At baseline, 59% of the myocardial segments were dysfunc-
tional (wall thickening < 45%). Of the dysfunctional seg-
ments, 74% was viable (TEI < 50%) and MVO was present
in 13%. In a multivariate analysis, baseline wall thickening,
segmental strain, and infarct (TEI) were all statistically signif-
icantly related; however, based on the t statistic, wall thicken-
ing and segmental strain were stronger predictors for wall
thickening recovery compared with infarct or MVO. In the
CTO territory, 59% of the segments were dysfunctional and
96% of the dysfunctional segments were viable (TEI < 50%).
In multivariate analysis, segmental strain was an independent
predictor for regional wall thickening recovery, incremental to
baseline wall thickening and infarct (coefficient − 0.44, SE
0.14, t − 3.10, p = 0.002; Table 4).
Discussion
This is the first study evaluating the recovery and value of
global and segmental myocardial strains in STEMI patients
with a concurrent CTO, and the first to determine the effect of
CTO-PCI on strain recovery. The main findings are the fol-
lowing: (1) Global and segmental strains improved over time,
with no significant treatment effect of CTO-PCI; (2) GLS was
a significant predictor for functional outcome incremental to
infarct size, LV function, and clinical parameters; however, for
mortality, infarct size remained the strongest predictor; and (3)
segmental strain is incremental to TEI in predicting regional
wall thickening recovery, especially in the CTO territory.
Global strain
Although strain significantly recovered at follow-up, we did
not find a beneficial effect of CTO-PCI compared with no-
CTO PCI on this recovery, which is consistent with the main
EXPLORE trial results. FT-CMR strain has substantial clini-
cal potential to be of diagnostic and prognostic value. Global
strain measurements are highly reproducible with good to
Fig. 2 Recovery of global strain
in the total cardiovascular
magnetic resonance population
from baseline to follow-up.
Global longitudinal strain (GLS)
(left) and global circumferential
strain (GCS) (right) from baseline
to 4-month follow-up. Whiskers
indicate standard deviation
Table 1 Recovery of global strain
comparing CTO-PCI versus no-
CTO PCI
GLS (%) Total (n = 166) p value CTO-PCI (n = 71) No-CTO PCI (n = 95) p value*
Baseline − 14.3 (6.2) − 13.9 (6.5) − 14.6 (6.0) 0.53
Follow-up − 16.1 (6.0) − 16.3 (5.8) − 15.9 (6.1) 0.68
Change − 1.8 (4.3) < 0.001† − 2.4 (4.2) − 1.4 (4.3) 0.14
GCS (%) Total (n = 160) p value CTO-PCI (n = 73) No-CTO PCI (n = 87) p value*
Baseline − 19.6 (7.1) − 19.5 (7.2) − 19.7 (7.1) 0.90
FU − 21.2 (7.1) − 20.9 (6.7) − 21.5 (7.4) 0.60
Change − 1.7 (4.7) < 0.001† − 1.4 (4.5) − 1.9 (4.9) 0.55
*Difference between CTO-PCI and no-CTO PCI. Outcomes were analyzed using paired Student’s t test. Data are
mean ± SD
† Significant recovery of strain from baseline to 4-month follow-up
GLS, global longitudinal strain; GCS, global circumferential strain; CTO, chronic total occlusion; PCI, percuta-
neous coronary intervention
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excellent intra- and inter-reproducibility and analysis appears
not to be influenced by the level of training [7, 18]. However,
only limited data is available on reference values of strain in
healthy subjects. LVEF and LVEDV are frequently used in
predicting patient prognosis; nonetheless, they are limited as
contractility is not measured and they are affected by patient
heart rate, loading conditions, and heart valve function [19].
We found that GLS is an independent predictor for global LV
function, incremental to LVEF and LVEDV. In a beating heart,
there are two longitudinal movements, shortening and
Table 2 Prediction of left
ventricular ejection fraction at
4-month follow-up (n = 129)
Univariate analysis Multivariate analysis
Beta 95% CI p value Beta 95% CI p value
Age (years) − 0.01 − 0.20 to 0.18 0.93
Male − 1.31 − 7.29 to 4.66 0.67
Diabetes − 8.06 − 13.00 to − 3.12 0.002
Infarct LAD − 4.11 − 7.77 to − 0.45 0.03
CTO LAD 1.84 − 2.50 to 6.18 0.40
CTO-PCI 0.85 − 2.88 to 4.57 0.65
Baseline LVEF (%) 0.70 0.60 to 0.81 < 0.001 0.45 0.29 to 0.60 < 0.001
Baseline LVEDV (ml/m2) − 0.22 − 0.29 to − 0.15 < 0.001 − 0.08 − 0.13 to − 0.02 0.005
MVO present − 6.64 − 10.18 to − 3.10 < 0.001 − 2.48 − 4.81 to − 0.14 0.04
Baseline infarct size (g) − 0.46 − 0.61 to − 0.30 < 0.001
Baseline GLS (%) − 1.20 − 1.41 to − 0.98 < 0.001 − 0.40 − 0.68 to − 0.12 0.006
Baseline GCS (%) − 1.18 − 1.35 to − 1.00 < 0.001
Stepwise forward selection of variables was used for multivariable linear regression
CI, confidence interval; CTO, chronic total occlusion; LAD, left anterior descending artery; LVEDV, left ventric-
ular end-diastolic volume; LVEF, left ventricular ejection fraction; PCI, percutaneous coronary intervention;GLS,
global longitudinal strain; GCS, global circumferential strain; MVO, microvascular obstruction
Fig. 3 Kaplan-Meier curves
representing long-term mortality
in patients with GCS < − 14% and
patients with GCS > − 14%.
Kaplan-Meier estimates of the
cumulative event rates
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lengthening (mainly reflecting GLS), and two transversal
movements, narrowing and widening (mainly reflecting
GCS). The cardiac cycle consists of different phases as de-
scribed in more detail by Torrent-Guasp et al [20]. In short, (1)
a decrease in the transversal diameter of the base caused by
basal loop contraction (narrowing movement), (2) a decrease
in the longitudinal axis (shortening movement), (3) an in-
crease in the longitudinal axis (lengthening movement), and
(4) an increase in the transversal diameter of the base are
conditioned by the relaxation of the ventricular walls and wid-
ening movement [20]. GLS is mainly determined by suben-
docardial myofibers (the basal loop), which are more prone to
early myocardial damage before global LV parameters are
affected. Therefore, diminished GLS is an early marker of
LV dysfunction. This could explain why GLS was the best
predictor of LV preservation at follow-up. GCS is largely
based on contraction of circumferential myofibers, which stay
mostly preserved during early LV deterioration and serve as a
restriction to prevent expansion of the LV [21].
For mortality, infarct size remained the strongest predictor.
Previous reports regarding the prognostic value of global
strain have been conflicting. In a study with 470 ischemic
and non-ischemic cardiomyopathy patients, GLS was a strong
predictor for mortality incremental to LVEF and infarct size
[22]. In 74 STEMI patients, GCS was able to predict preser-
vation of global function (LVEF > 50%) at follow-up similar
to infarct size [23]. However, in a study of 65 STEMI patients,
GLS was not able to predict adverse LV remodeling [5]. In
another study, GLS did not improve risk stratification com-
pared with baseline characteristics and CMR indices in 323
STEMI patients [24]. In the largest strain study thus far (1,235
MI patients), GLS did have incremental prognostic value over
LVEF and infarct size to predict mortality [25]. Nonetheless,
most studies performed are of small sample sizes and with
relative short follow-up.
Segmental strain
Segmental strain significantly recovered at follow-up. Yet,
there was no effect of CTO-PCI, compared with no-CTO
PCI, on global nor on segmental strain recovery. However,
we have previously shown that wall thickening significantly
improves after CTO-PCI compared with no-CTO PCI in the
dysfunctional CTO territory [11]. Although strain has the po-
tential to detect more subtle regional differences, we could not
reproduce this finding with segmental strain, although the
number of segments was relatively low. Furthermore, it is
important to mention that previous studies reported high de-
grees of measurement variability and relatively poor segmen-
tal strain reproducibility [26, 27]. Therefore, segmental strain
data may be less reliable and its use in clinical practice should
be done with caution.
We did find that segmental strain was a strong predictor for
wall thickening recovery, incremental to infarct, especially in
the dysfunctional CTO territory. This finding is consistent
Table 3 Serial cardiovascular magnetic resonance outcomes: recovery of segmental circumferential strain

















Baseline − 17.2 (9.2) – − 17.5 (10.0) − 16.8 (8.9) 0.41 − 15.8 (8.7) − 16.3 (9.1) 0.46
Follow-up − 19.7 (9.4) – − 20.2 (9.8) − 19.3 (9.3) 0.33 − 19.1 (9.3) − 18.6 (9.7) 0.68
Change − 2.4 (8.9) < 0.001† − 2.5 (9.5) − 2.5 (8.5) 0.50 − 3.2 (9.4) − 2.3 (9.0) 0.42
*Outcomes were analyzed using multilevel analysis (linear regression); the following fixed effects were included: randomization outcome and baseline
segmental strain
† Significant recovery of strain from baseline to 4-month follow-up
Data are mean ± SD. s, number of segments; CTO, chronic total occlusion; PCI, percutaneous coronary intervention; SWT, segmental wall thickening
Table 4 Multivariate analysis of predictors of regional recovery
(change in wall thickening)
Coefficient SE t p value*
Dysfunctional segments (s = 1202)
Segmental strain − 0.31 0.08 − 3.85 < 0.001
Wall thickening − 0.55 0.05 − 11.96 < 0.001
Infarct (TEI) − 0.08 0.04 − 1.74 0.08
MVO present − 6.43 2.45 − 2.96 0.003
CTO-PCI 4.85 2.45 1.98 0.05
Dysfunctional segments in CTO territory (s = 498)
Segmental strain − 0.44 0.14 − 3.17 0.002
Wall thickening − 0.45 0.08 − 5.39 < 0.001
Infarct (TEI) − 0.12 0.08 − 1.51 0.13
CTO-PCI 7.73 3.06 2.53 0.01
*Outcomes were analyzed using multilevel analysis (linear regression);
the following fixed effects were included: baseline segmental wall thick-
ening, baseline transmural extent of infarction, presence of microvascular
obstruction, randomization outcome, and baseline segmental strain
s, number of segments; MVO, microvascular obstruction; CTO, chronic
total occlusion; PCI, percutaneous coronary intervention; TEI, transmural
extent of infarction
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with previous data: in 45 STEMI patients, segmental strain
was incremental to infarct and MVO in predicting recovery
of wall thickening [28]. However, another study in STEMI
patients showed that segmental strain was only a mild predic-
tor of wall thickening recovery and inferior compared with
infarct [29]. Furthermore, segmental strain and infarct
transmurality are also related, as segmental strain is a predictor
for infarcted segments [30]. Therefore, the incremental predic-
tive value and exact relation of segmental strain and infarct
needs further examination as, different from infarct (TEI),
segmental strain can be measured without the use of a contrast
agent, making it a possible alternative in patients with contrast
allergy or renal failure.
Clinical use of myocardial strain assessment
In our high-risk patient population, new risk stratification pa-
rameters may be relevant to adequately select patients for
CTO revascularization. None of the randomized CTO trails
conducted showed a beneficial effect of CTO-PCI on clinical
outcome nor on LVF, although ischemia and viability testing
prior to inclusion were not mandated. It remains to be deter-
mined what the optimal patient selection threshold for CTO
revascularization is and whether optimal selection will indeed
lead to improved outcomes. Further studies are needed to in-
vestigate the true value of (stress) FT-CMR strain in clinical
evaluation and whether it can be used as a diagnostic and
prognostic tool to select patients that might benefit from PCI.
Limitations
There are several limitations applicable to this study.
Unfortunately, not all CMRs were suitable for strain analysis
and not all patients underwent baseline CMR. Furthermore,
infarct data was not available in all patients and only 4% of the
dysfunctional segments in the CTO territory were non-viable
(TEI > 50%), making sample size relatively small and under-
powered. Infarct size was probably decreased by the presence
of collaterals, which were present in > 90% of the patients. As
with all randomized trials, patient selection has occurred. The
mortality rate was relatively low in our study cohort with the
risk of overfitting the model and EXPLORE was not powered
for clinical outcomes.
Conclusion
Global and segmental myocardial strains, measured by FT-
CMR, improved significantly over time in STEMI patients
with a concurrent CTO, with no beneficial effect of CTO-
PCI. GLS was an independent predictor for functional recov-
ery, incremental to infarct size, LVEF, and clinical parameters.
Although GCS predicted mortality, infarct size remained the
strongest predictor. Segmental circumferential strain was an
independent predictor for regional LV recovery in the dys-
functional CTO territory.
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